[HTML][HTML] Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection …
KA Tendl-Schulz, F Rössler, P Wimmer, UM Heber… - Virchows Archiv, 2020 - Springer
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
KA Tendl-Schulz, F Rössler, P Wimmer… - Virchows Archiv …, 2020 - search.ebscohost.com
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
KA Tendl-Schulz, F Rössler, P Wimmer… - Virchows Archiv: an …, 2020 - sonar.ch
English Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB)
is essential for determining breast cancer molecular subtype for therapy planning. However …
is essential for determining breast cancer molecular subtype for therapy planning. However …
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
KA Tendl-Schulz, F Rössler, P Wimmer… - Virchows Archiv: an …, 2020 - folia.unifr.ch
English Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB)
is essential for determining breast cancer molecular subtype for therapy planning. However …
is essential for determining breast cancer molecular subtype for therapy planning. However …
[PDF][PDF] Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection …
KA Tendl-Schulz, F Rössler, P Wimmer, UM Heber… - 2020 - scholar.archive.org
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
KA Tendl-Schulz, F Rössler, P Wimmer… - Virchows Archiv: an …, 2020 - europepmc.org
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
KA Tendl-Schulz, F Rössler… - Virchows Archiv …, 2020 - pubmed.ncbi.nlm.nih.gov
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …
[HTML][HTML] Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection …
KA Tendl-Schulz, F Rössler, P Wimmer… - Virchows …, 2020 - ncbi.nlm.nih.gov
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
KA Tendl-Schulz, F Rössler, P Wimmer, UM Heber… - Virchows …, 2020 - zora.uzh.ch
Reliable determination of Ki67 labeling index (Ki67-LI) on core needle biopsy (CNB) is
essential for determining breast cancer molecular subtype for therapy planning. However …
essential for determining breast cancer molecular subtype for therapy planning. However …